Skip to main navigation
Skip to search
Skip to main content
OSU Center for Health Sciences Research Profiles Home
Help & Contact
Link opens in a new tab
Search content at OSU Center for Health Sciences Research Profiles
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Press/Media
Examination of Immune Response to SARS-COV-2 in PBMCs and serum
Davinia Devaraj
, Harini Senthil
,
Kelly McCracken
,
Bart Ford
Pharmacology and Physiology
Research output
:
Contribution to conference
›
Poster
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Examination of Immune Response to SARS-COV-2 in PBMCs and serum'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Immune Response
100%
Severe Acute Respiratory Syndrome
100%
Peripheral Blood Mononuclear Cell
100%
Immunological Memory
83%
T Cell
66%
Blood Level
33%
B Cell
33%
ELISA
33%
COVID-19
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Immunology
33%
Normal Human
16%
Antibody Blood Level
16%
Immunoglobulin G
16%
Immunocompetent Cell
16%
Sample Size
16%
Optical Density
16%
Cell Count
16%
Memory T Cell
16%
Enzyme-Linked Immunospot Assay
16%
Cell Antibody
16%
Humoral Antibody
16%
Keyphrases
Immune Response
100%
Peripheral Blood Mononuclear Cells
100%
COVID-19
100%
Immune Memory
50%
B Cells
20%
T Cells
20%
Serum Samples
20%
Serum Concentration
20%
ImmunoSpot
20%
Between-person
10%
Virus
10%
Autoreactive T Cells
10%
Adult Female
10%
Illness
10%
Incubation
10%
Humoral Antibody Response
10%
Biotechnology
10%
Antibody Concentration
10%
Immune Cells
10%
Cell-to-cell
10%
Infected Cells
10%
Small Sample Size
10%
Healthy Adults
10%
Number of Days
10%
Optical Density
10%
Pfizer
10%
IgG Antibody
10%
Memory T Cells
10%
COVID-19 Vaccine
10%
SARS-CoV-2 Infection
10%
Adaptive Immune Response
10%
Confirmed Cases
10%
Concentration Cell
10%
Memory Immunity
10%
Vaccine Dose
10%
T-cell Count
10%
Potential Correlation
10%
IFN-y
10%
Single Colour
10%
ELISpot Assay
10%
Cell Samples
10%
Comirnaty
10%
IgG ELISA
10%
Antibody Immunity
10%
Human IgG
10%
Pharmacology, Toxicology and Pharmaceutical Science
Severe Acute Respiratory Syndrome
100%
Infection
33%
Enzyme-Linked Immunosorbent Assay
33%
SARS Coronavirus
33%
Disease
16%
Normal Human
16%
Immunoglobulin G
16%
COVID-19 Vaccine
16%
Humoral Antibody
16%
Cell Antibody
16%
Enzyme-Linked Immunospot Assay
16%
Messenger RNA
16%
Carbon Dioxide
16%
Veterinary Science and Veterinary Medicine
Severe Acute Respiratory Syndrome
100%
Peripheral Blood Mononuclear Cell
100%
T Cell
66%
SARS Coronavirus
33%
B Cell
33%
Memory T Cell
16%